ロード中...
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
Unresectable hepatocellular carcinoma (uHCC) is one of the most lethal and prevalent cancers worldwide, and current systemic therapeutic options for uHCC are limited. Lenvatinib, a multiple receptor tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFRs) and fibrobl...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6010799/ https://ncbi.nlm.nih.gov/pubmed/29733511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1517 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|